This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1545968308317437v1 1545968308317437v2 23/1/67    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cordo, P. Articles by Skoss, R. Search for Related Content PubMed PubMed Citation Articles by Cordo, P. Articles by Skoss, R. Pubmed/NCBI databases Medline Plus Health Information Movement Disorders Stroke Social Bookmarking                         What's this?

Assisted Movement With Enhanced Sensation (AMES): Coupling Motor and Sensory to Remediate Motor Deficits in Chronic Stroke Patients

¹ From the Neurological Sciences Institute, Oregon Health & Science University, and Research & Development, AMES Technology, Inc, Portland, Oregon
² From the Department of Neurology, Oregon Health & Science University, Portland, Oregon
³ From Research & Development, AMES Technology, Inc, Portland, Oregon
⁴ From the Department of Physical Therapy, Temple University, Philadelphia, Pennsylvania
⁵ From the Neurological Sciences Institute, Oregon Health & Science University, Portland, Oregon
⁶ From the School of Physiotherapy, Curtin University of Technology, Perth, Australia

^* To whom correspondence should be addressed. E-mail: cordop{at}ohsu.edu.

	Abstract

Background. Conventional methods of rehabilitation in patients with chronic, severe motor impairments after stroke usually do not lessen paresis. Objective. A novel therapeutic approach (assisted movement with enhanced sensation [AMES]) was employed in a medical device phase I clinical trial to reduce paresis and spasticity and, thereby, to improve motor function. Methods. Twenty subjects more than 1 year poststroke with severe motor disability of the upper or lower extremity were studied. A robotic device cycled the ankle or the wrist and fingers at 5°/s through ±17.5°in flexion and extension while the subject assisted this motion. Feedback of the subject’s active torque was displayed on a monitor. Simultaneously, 2 vibrators applied a 60 pps stimulus to the tendons of the lengthening muscles, alternating from flexors to extensors as the joint rotation reversed from extension to flexion, respectively. Subjects treated themselves at home for 30 min/day for 6 months. Every other day prior to treatment, the therapy device performed automated tests of strength and joint positioning. Functional testing was performed prior to enrollment, immediately after completing the protocol, and 6 months later. Functional tests included gait and weight distribution (lower extremity subjects only) and the Stroke Impact Scale. Results. Most subjects improved on most tests, and gains were sustained for 6 months in most subjects. No safety problems arose. Conclusion. The AMES strategy appears safe and possibly effective in patients with severe chronic impairments. The mechanism underlying these gains is likely to be multifactorial.

First published on July 21, 2008, doi:10.1177/1545968308317437

Neurorehabilitation and Neural Repair 2009;23:67.

A more recent version of this article appeared on January 1, 2009
This version was published on October 21, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?